The International Journal of Tuberculosis and Lung Disease

GPT-4, artificial intelligence and implications for publishing
pp. 425-426(2)
Authors: Ong, C. W. M.; Blackbourn, H. D.; Migliori, G. B.

Ukraine embraces innovation in its fight against another deadly foe: TB
pp. 427-428(2)
Authors: Denysenko, V.; Terleyeva, Y.; Kondratyuk, S.; McKenna, L.; Furin, J.

Literature Highlights
pp. 429-431(3)
Authors: Makek, M. J.; Tiberi, S.; Felker, I.; Amorim, G. G. C.

Digital approaches to reducing TB treatment loss to follow-up
pp. 432-437(6)
Authors: Oeser, C.; Rangaka, M. X.; Abubakar, I.

Current status and future prospects of TB digital treatment adherence technology use in China
pp. 438-443(6)
Authors: Ni, N.; Wang, N.; Veronese, V.; Wang, M-Z.; Wang, J-W.; Wang, C-H.; Li, T.; Xia, Y-Y.; Huang, F.; Zhao, Y-L.

Smoked drug use in patients with TB is associated with higher bacterial burden
pp. 444-450(7)
Authors: Myers, B.; Carney, T.; Rooney, J.; Malatesta, S.; Ragan, E. J.; White, L. F.; Natcheva, H.; Bouton, T. C.; Weber, S. E.; Farhat, M.; McIlleron, H.; Theron, D.; Parry, C. D. H.; Horsburgh, C. R.; Warren, R. M.; Jacobson, K. R.

Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications
pp. 451-457(7)
Authors: Rich, M. L.; Khan, U.; Zeng, C.; LaHood, A.; Franke, M. F.; Atwood, S.; Bastard, M.; Burhan, E.; Danielyan, N.; Dzhazibekova, P. M.; Gadissa, D.; Ghafoor, A.; Hewison, C.; Islam, M. S.; Kazmi, E.; Khan, P. Y.; Lecca, L.; Maama, L. B.; Melikyan, N.; Naing, Y. Y.; Philippe, K.; Saki, N. A.; Seung, K. J.; Skrahina, A.; Tefera, G. B.; Varaine, F.; Vilbrun, S. C.; Võ, L.; Mitnick, C. D.; Huerga, H.; on behalf of the endTB Observational Study Team

Understanding patient-level costs of weekly isoniazid-rifapentine (3HP) among people living with HIV in Uganda
pp. 458-464(7)
Authors: Sung, J.; Musinguzi, A.; Kadota, J. L.; Baik, Y.; Nabunje, J.; Welishe, F.; Bishop, O.; Berger, C. A.; Katahoire, A.; Nakitende, A.; Nakimuli, J.; Akello, L.; Kasidi, J. R.; Kunihira Tinka, L.; Kamya, M. R.; Sohn, H.; Kiwanuka, N.; Katamba, A.; Cattamanchi, A.; Dowdy, D. W.; Semitala, F. C.

Lung function decline in non-tuberculous mycobacterial pulmonary disease according to disease severity
pp. 465-470(6)
Authors: Park, H-J.; Kim, J-Y.; Kim, H-J.; Yim, J-J.; Kwak, N.

Diagnosis, treatment and transmission of rifampicin-resistant TB in the Netherlands, 2010–2019
pp. 471-477(7)
Authors: de Vries, G.; Akkerman, O.; Boeree, M.; van Hest, R.; Kamst, M.; de Lange, W.; Magis-Escurra, C.; Meijer, W.; van Soolingen, D.

Highlighting the characteristics of TB disease in older people
pp. 478-480(3)
Authors: Louie, J. K.; Keh, C.; Agraz-Lara, R.; Phillips, A.; Graves, S.

Prevalence of COVID-19 infection in TB clinics in Kampala, Uganda
pp. 481-483(3)
Authors: Otaalo, B.; Cevik, M.; Mwebesa, E.; Nabisere-Arinaitwe, R.; Zawedde-Muyanja, S.; Nampala, J.; Nanziri, C.; Alinaitwe, L.; Aber, F.; Bayigga, J.; Nankinga, B.; Laker, E.; Owarwo, N. C.; Sabiiti, W.; Adakun, S.; Kirenga, B.; Turyahabwe, S.; Sloan, D. J.; Sekaggya-Wiltshire, C.

Higher yield using an event-based vs. door-to-door approach for active case-finding for TB
pp. 484-486(3)
Authors: Malhotra, A.; Mukiibi, J.; Kitonsa, P. J.; Nalutaaya, A.; Kamoga, C. E.; Robsky, K. O.; Isooba, D.; Nantale, M.; Nakasolya, O.; Kayondo, F.; Mukiibi, M.; Kiyonga, R.; Dowdy, D. W.; Katamba, A.; Kendall, E. A.

Clinical and imaging features of drug-susceptible and multidrug-resistant TB in Korean adults
pp. 487-489(3)
Authors: Kim, S-H.; Yoo, J. Y.; Cho, H. S.; Kim, S. R.; Cho, J. Y.; Youk, S.; Kim, E-G.; Shin, Y. M.; Choe, K. H.; Lee, K. M.; Lee, H.; Yang, B.

Michael Dee Iseman, MD – the passing of a legend
pp. 490-491(2)
Authors: Daley, C. L.; Chan, E. D.; Reichman, L. B.